CSIMarket


Watson Pharmaceuticals Inc  (WPI)
Other Ticker:  
 
    Sector  Consumer Non Cyclical    Industry Legacy
   Industry Legacy
   Sector  Consumer Non Cyclical

Watson Pharmaceuticals Inc

WPI's Fundamental analysis






Looking into Watson Pharmaceuticals Inc growth rates, revenue grew by 18.82 % in III. Quarter 2012 from the same quarter a year ago. Ranking at No. 70

Legacy industry recorded deterioration of revenues by

Watson Pharmaceuticals Inc's net income grew by 12.63 % in III. Quarter 2012 year on year, above company average,

More on WPI's Growth


Watson Pharmaceuticals Inc
current PE on trailing twelve month basis is below Legacy industry average.

Watson Pharmaceuticals Inc realized cash outflow of $ 0.46per share in trailing twelve-month period.
Company
0
PE TTM   
Industry
92.68
PE TTM    
Legacy industry's Price to Sales ratio is at 0.85.
With annual estimated revenue growth of 19.97 % for 2012, Company's P/S ratio improved to 0.

More on WPI's Valuation
 
 Total Debt (Millions $) 1,221
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 853,919
 Net Income/Employee (TTM) $ 24,544
 Receivable Turnover (TTM) 5.71
 Tangible Book Value (Per Share $) 2.91

Watson Pharmaceuticals Inc
current PE on trailing twelve month basis is below Legacy industry average.

Watson Pharmaceuticals Inc realized cash outflow of $ 0.46per share in trailing twelve-month period.
Company
0
PE TTM   
Industry
92.68
PE TTM    
Legacy industry's Price to Sales ratio is at 0.85.
With annual estimated revenue growth of 19.97 % for 2012, Company's P/S ratio improved to 0.

More on WPI's Valuation

  Market Capitalization (Millions $) -
  Shares Outstanding (Millions) 128
  Employees 6,686
  Revenues (TTM) (Millions $) 5,709
  Net Income (TTM) (Millions $) 164
  Cash Flow (TTM) (Millions $) 59
  Capital Exp. (TTM) (Millions $) -124
  Total Debt (Millions $) 1,221
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 853,919
  Net Income/Employee(TTM) $ 24,544
  Receivable Turnover Ratio (TTM) 5.71
  Tangible Book Value (Per Share $) 2.91

  Market Capitalization (Millions $) -
  Shares Outstanding (Millions) 128
  Employees 6,686
  Revenues (TTM) (Millions $) 5,709
  Net Income (TTM) (Millions $) 164
  Cash Flow (TTM) (Millions $) 59
  Capital Exp. (TTM) (Millions $) -124

WPI's Profitability Comparisons
Watson Pharmaceuticals Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2012 to 6.92 % from 7.1 % in II. Quarter.

Watson Pharmaceuticals Inc net profit margin of 5.97 % is currently ranking no. 6 in Legacy industry, ranking no. 62 in Consumer Non Cyclical sector and number 1697 in S&P 500.


Profitability by Segment
Generic pharmaceutical products 35.42 %
Distribution 5.72 %



  Ratio
   Capital Ratio (MRQ) 1.58
  Total Debt to Equity (MRQ) 0.33
  Tangible Leverage Ratio (MRQ) 7.54
  Asset Turnover Ratio (TTM) 0.86
  Inventory Turnover Ratio (TTM) 3.69



Watson Pharmaceuticals Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2012 to 6.92 % from 7.1 % in II. Quarter.

Watson Pharmaceuticals Inc net profit margin of 5.97 % is currently ranking no. 6 in Legacy industry, ranking no. 62 in Consumer Non Cyclical sector and number 1697 in S&P 500.

More on WPI's Key Ratios





Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DVA's Profile

Stock Price

DVA's Financials

Business Description

Fundamentals

Charts & Quotes

DVA's News

Suppliers

DVA's Competitors

Customers & Markets

Economic Indicators

DVA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071